Form 4: Humana Executive George Renaudin II Reports Changes in Beneficial Ownership

George Renaudin II, President of Medicare & Medicaid at Humana Inc., reports changes in his beneficial ownership of company stock and derivative securities.

Summary

• On April 1, 2024, George Renaudin II, President of Medicare & Medicaid at Humana Inc., filed a Form 4 with the SEC detailing changes in his beneficial ownership of Humana securities.
• The report indicates a disposition of 9,623 Humana common shares.
• Renaudin also holds options to purchase 4,162 shares at $510.2425, exercisable from February 24, 2024, and options to purchase 6,966 shares at $367.21, exercisable from February 21, 2025.
• He also holds various restricted stock units (RSUs) that will vest at different dates in the future, representing a right to receive 1,241, 230, 609, and 719 shares of Humana common stock respectively.
• Additionally, Renaudin holds 162 phantom stock units under the Humana Retirement Equalization Plan, with 8 units acquired on March 28, 2024, at a price of $346.72.

Sentiment

Score: 5

Explanation: The document is a standard SEC filing reporting changes in beneficial ownership. It doesn't inherently convey positive or negative sentiment, but the disposition of shares could be viewed with slight caution.

Negatives

• The disposition of 9,623 Humana common shares by a high-ranking officer could be interpreted negatively by some investors.

Future Outlook

The document does not contain any specific forward-looking statements or guidance.

Industry Context

Form 4 filings are a routine part of corporate governance and provide transparency into the trading activities of company insiders. Monitoring these filings can offer insights into management's perspective on the company's stock.

Stakeholder Impact

• The reported transactions may influence investor sentiment regarding Humana's stock.

Key Dates